Latest California Healthline Stories
Medical Responses To Opioid Addiction Vary By State, Analysis Finds
The study also found that the largest percentage of medical coverage claims related to opioid abuse and dependence nationally come from older patients — those ages 51 to 60.
Quantity Over Quality? Minorities Shown To Get An Excess Of Ineffective Care
The researchers looked at 11 services that medical groups have said are often unnecessary and found that blacks and Hispanics got them at higher rates than whites.
If Insurance Market Crashes, Can Lawmakers Put The Pieces Back Together?
Actions by the Trump administration are putting pressure on the fragile market for individuals who buy their own coverage, but analysts say it should be able to rebound.
Daylight On Diabetes Drugs: Nevada Bill Would Track Insulin Makers’ Profits
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices.
Former Pharma Reps’ New Mission: To School Docs On High Drug Costs
One insurer is turning the tables on drugmakers with what may be a new job category: a sales force for cost-effective medicine.
Hospitals Now Tap Lawyers To Fulfill Patients’ Legal Needs
About 300 health care systems around the country have set up medical-legal partnerships to help patients who are dealing with legal problems that affect their health.
Covered California Tells Insurers To Plan For The Worst
The state health insurance exchange has instructed its participating health plans to submit alternative proposals for premium hikes that would offset the potential loss of an important source of federal funding.
As Government-Funded Cancer Research Sags, Scientists Fear U.S. Is ‘Losing Its Edge’
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.
When An Insurer Balks And Treatment Stops
A 22-year old man from Orange County, Calif., alleges in a lawsuit that his health insurer stopped paying for a crucial — and expensive — immunotherapy drug, leading him to become seriously ill. Treatments for patients with similar conditions are increasingly denied or interrupted, experts and patient advocates say.
Drug Rebates Reward Industry Players — And Often Hurt Patients
A new JAMA study examines how drug rebates can direct money to middlemen and force Medicare patients to cough up more money.